Volume 24, Number 6—June 2018
Dispatch
Marburg Virus Infection in Egyptian Rousette Bats, South Africa, 2013–20141
Janusz T. Pawęska
, Petrus Jansen van Vuren, Alan Kemp, Nadia Storm, Antoinette A. Grobbelaar, Michael R. Wiley, Gustavo Palacios, and Wanda Markotter
, Petrus Jansen van Vuren, Alan Kemp, Nadia Storm, Antoinette A. Grobbelaar, Michael R. Wiley, Gustavo Palacios, and Wanda Markotter
Table 2
Base pair changes between reference MARV strains and MARV from Matlapitsi Cave, Limpopo Province, South Africa, 2013*
| Sequence type, MARV gene |
Strain, no. (%) |
|||
|---|---|---|---|---|
| Ozolin 1975 |
Angola 2005 |
Musoke 1980 |
Uganda 2009 |
|
| Nucleotide sequence | ||||
| Nucleocapsid | 9 (0.43) | 120 (5.8) | 112 (5.4) | 123 (5.9) |
| Viral protein 35 | 4 (0.43) | 56 (5.7) | 37 (3.7) | 58 (5.9) |
| Viral protein 40 | 5 (0.57) | 54 (5.9) | 50 (5.5) | 52 (5.7) |
| Glycoprotein | 17 (0.85) | 198 (9.7) | 185 (9.0) | 190 (9.3) |
| Viral protein 30 | 4 (0.48) | 55 (6.5) | 49 (5.8) | 55 (6.5) |
| Viral protein 24 | 2 (0.26) | 43 (5.7) | 38 (5.0) | 34 (4.4) |
| Polymerase |
43 (0.6) |
469 (6.7) |
425 (6.1) |
479 (6.8) |
| Amino acid sequence | ||||
| Nucleocapsid | 0 | 11 (1.6) | 12 (1.7) | 11 (1.6) |
| Viral protein 35 | 0 | 4 (1.3) | 1 (0.3) | 4 (1.3) |
| Viral protein 40 | 1 (0.34) | 4 (1.4) | 3 (1.0) | 3 (1.0) |
| Glycoprotein | 8 (1.2) | 60 (8.8) | 61 (9.0) | 63 (9.3) |
| Viral protein 30 | 1 (0.36) | 8 (2.9) | 13 (4.7) | 10 (3.6) |
| Viral protein 24 | 0 | 2 (0.79) | 2 (0.79) | 1 (0.4) |
| Polymerase | 12 (0.52) | 83 (3.6) | 87 (3.7) | 87 (3.7) |
*Matlapitsi Cave MARV sequences were from specimen no. SPU 191/13 from bat no. 2,764 (GenBank accession no. MG725616). MARV, Marburg virus.
1Some preliminary results from this study were presented at the 6th International Symposium on Filoviruses; March 30–April 2, 2014; Galveston, Texas, USA.
Page created: May 17, 2018
Page updated: May 17, 2018
Page reviewed: May 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.